ClinicalTrialsFinder

Relapsed B-cell Acute Lymphoblastic Leukemia Clinical Trials in Tianjin

1 recruitingTianjin, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

CAR-T-19 Injection in the Treatment of CD19-positive Relapsed/Refractory B-ALL

Relapsed B-cell Acute Lymphoblastic LeukemiaRefractory B-cell Acute Lymphoblastic Leukemia
Beijing Yongtai Ruike Biotechnology Company Ltd100 enrolled1 locationNCT06179524